Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
63.40
+4.75 (8.10%)
At close: Aug 25, 2026, 4:00 PM EDT
64.51
+1.11 (1.75%)
After-hours: Aug 25, 2026, 7:52 PM EDT
Spruce Biosciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
22
Market Cap
182.21M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 4.91M | -5.18M | -51.32% |
| Dec 31, 2023 | 10.09M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| LENZ Therapeutics | 21.48M |
| Equillium | 4.39M |
| NRx Pharmaceuticals | 3.39M |
| Connect Biopharma Holdings | 2.95M |
| Milestone Pharmaceuticals | 2.34M |
| Kazia Therapeutics | 1.27M |
| Outlook Therapeutics | -1.16M |
SPRB News
- 1 day ago - Spruce Biosciences Announces Positive Pre-BLA Meetings with FDA and Confirms BLA Submission for TA-ERT on Track for Q4 2026 - Business Wire
- 8 days ago - Spruce Biosciences price target lowered to $104 from $123 at Guggenheim - TheFly
- 8 days ago - Cure Sanfilippo, National MPS agree to make $5.5M investment in Spruce - TheFly
- 8 days ago - Spruce Biosciences reports Q2 EPS ($6.68), consensus ($5.93) - TheFly
- 8 days ago - Spruce Biosciences sees cash runway into 2H27 - TheFly
- 8 days ago - Spruce Biosciences price target lowered to $144 from $150 at Citizens - TheFly
- 13 days ago - Spruce Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates - Business Wire
- 13 days ago - Cure Sanfilippo Foundation and National MPS Society Make $5.5 Million Strategic Investment in Spruce Biosciences - Business Wire